BNTC Prakiraan rega marang bathi Benitec Biopharma Inc
This price action chart on GURU.Markets shows a P/E ratio of 0.00. Benitec Biopharma Inc. (BNTC) is attracting leading genetics specialists by offering them stock options and the opportunity to shape the future of medicine. The company focuses on developing gene silencing methods, though it is currently unprofitable as its products undergo FDA review and the cost of therapy will be determined upon completion of testing.
Rincian metrik keuangan lan pasar Benitec Corp (BNTC)
- kuotasi lan prakiraan analis:
- data kapitalisasi pasar:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas Benitec Biopharma Inc.|BNTC - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Benitec Biopharma Inc.|BNTC - Utang perusahaan|Utang-utang marang kapitalisasi buku Benitec Biopharma Inc|BNTC - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Benitec Biopharma|Likuiditas cepet benitec.com
- statistik bathi lan rasio pasar:
BNTC - Bathi sawise pajeg|Proyeksi bathi mangsa ngarep Benitec Biopharma Inc.|BNTC - Nilai perusahaan marang bathi resik|Pangali Forward P/E Benitec|BNTC - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Benitec Biopharma Inc|BNTC - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Benitec Biopharma|BNTC - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan benitec.com|BNTC - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Benitec Biopharma Inc.
- data dodolan lan asil:
Analisis umum perusahaan:Benitec Biopharma
The specifics of Benitec Biopharma Inc. (BNTC) gene therapy development are associated with high toxicity risks and a liquidity deficit. The forward P/E reflects the ratio of the business's market value to projected net income. By analyzing the company's consensus P/E forecast, an investor assesses the extent to which expectations for future earnings are inflated. The indicator's trend reveals asset overvaluation amid volatility in the biotechnology sector. This tool characterizes the securities as a high-risk speculative asset.
Pesaing utama
Pangali Forward P/E TEM|Kapitalisasi marang proyeksi bathi Qiagen NV|Ionis Pharma - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep RGEN (Repligen Inc.)|Avidity Biosciences - Pangali Forward P/E|Rasio prakiraan rega marang bathi crisprtx.com|WGS: Pangali Forward P/E|Prakiraan rega marang bathi Ultragenyx Pharmaceutical Inc.|Prakiraan rega marang bathi BEAM|SRPT: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TWST|Rega marang bathi mangsa ngarep TXG (10xgenomics.com)|Pangali Forward P/E NTLA (Intellia Therapeutics, Inc.)|Kapitalisasi marang proyeksi bathi Stoke Therapeutics Inc (STOK)|BLFS - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Wave Pharma|Maze Therapeutics Inc (MAZE) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake SION (sionnatx.com)|PRME (Prime Medicine) - Pangali Forward P/E|TSHA: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E QURE|Pangali Forward P/E MeiraGTx Corp (MGTX)|Rega marang bathi mangsa ngarep REGENXBIO Inc. RGNX|Pangali mangsa ngarep rega marang bathi SLDB|OCGN - Rega marang bathi mangsa ngarep|Pacific Biosciences of California, Inc. (PACB) - Prakiraan rega marang bathi|DSGN: Pangali Forward P/E|Rocket Corp (RCKT) - Pangali Forward P/E|Prakiraan rega marang bathi FDMT|LXEO: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E KRRO|Kapitalisasi marang proyeksi bathi Editas Medicine Inc|Rega marang bathi mangsa ngarep Silence Therapeutics Inc. SLN|PRQR: Rasio rega marang bathi mangsa ngarep|Codexis Bio - Pangali Forward P/E|sangamo.com (SGMO) - Prakiraan rega marang bathi|NAUT (nautilus.bio) - Prakiraan rega marang bathi|MGX - Kapitalisasi marang proyeksi bathi|DTIL (Precision BioSciences, Inc.) - Pangali Forward P/E|Rega marang bathi mangsa ngarep GBIO|Rega marang bathi mangsa ngarep Boundless Bio, Inc. (BOLD)|exicuretx.com - Rasio rega marang bathi mangsa ngarep|Imunon - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep PHIO (Phio Pharmaceuticals Corp)|Mustang Bio Corp - Pangali Forward P/E|TransCode Therapeutics (RNAZ) - Prakiraan rega marang bathi|BNGO: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep APDN|Rega marang bathi mangsa ngarep bluebird bio|Rasio rega marang bathi mangsa ngarep IPA (ImmunoPrecise)|Pangali Forward P/E OMGA|Pangali Forward P/E Singular Genomics Corp (OMIC)|Pangali Forward P/E RGLS (Regulus Therapeutics)|syros.com - Rega marang bathi mangsa ngarep|Telesis Bio - Pangali Forward P/E|Rasio prakiraan rega marang bathi TRACON Pharmaceuticals Inc.|Unity Bio (UBX) - Rega marang bathi mangsa ngarep
